Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 41Unknown 7Terminated 7Withdrawn 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 1Arthritis, Rheumatoid 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Etanercept × Clear all
NCT03294954 2025-09-19

GINAKIT2

Baylor College of Medicine

Phase 1 Recruiting
70 enrolled
CNS

Neuroblastoma

NCT03976245 2024-11-29

Advanced Therapeutics in Rheumatoid Arthritis (RA)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 4 Recruiting
144 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡